Industry A Brighter 2025 for Biotechs: Transforming Underperformance Into New Opportunities. With emerging technologies and patient-focused strategies, will biotechs finally overcome past challenges and seize new opportunities for growth in 2025? Olivia ColemanFebruary 1, 2025 View Post